Edition:
United States

Active Biotech AB (ACTI.ST)

ACTI.ST on Stockholm Stock Exchange

2.13SEK
14 Dec 2017
Change (% chg)

-0.06kr (-2.74%)
Prev Close
2.19kr
Open
2.15kr
Day's High
2.19kr
Day's Low
2.09kr
Volume
179,108
Avg. Vol
282,915
52-wk High
21.90kr
52-wk Low
2.02kr

Chart for

About

Active Biotech AB is a Sweden-based company that focuses on pharmaceutical research and development in medical fields in which the immune system plays a central role. The Company’s research portfolio primarily includes projects for the development of drugs for the treatment of autoimmune and inflammatory diseases and cancer. As... (more)
No analyst recommendations are available for .

Overall

Beta: 3.11
Market Cap(Mil.): kr207.20
Shares Outstanding(Mil.): 96.82
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 198.20 16.04
EPS (TTM): -- -- --
ROI: -- -11.76 34.69
ROE: -- -36.72 15.46

BRIEF-Active Biotech ‍provides updated information about company's financial situation​

* ‍PROVIDES UPDATED INFORMATION ABOUT COMPANY'S FINANCIAL SITUATION​

Dec 07 2017

BRIEF-Active Biotech Announce Results In Arpeggio Phase II Trial With Laquinimod In Primary Progressive MS

* ACTIVE BIOTECH ANNOUNCE RESULTS IN ARPEGGIO PHASE II TRIAL WITH LAQUINIMOD IN PRIMARY PROGRESSIVE MS Source text for Eikon: Further company coverage:

Dec 01 2017

BRIEF-Active Biotech Q2 operating loss 23.1 mln SEK

* Active biotech ab q2 sales 5.1 million sek Source text for Eikon: Further company coverage: (Reporting By Anna Ringstrom)

Aug 10 2017

BRIEF-Active Biotech appoints Helen Tuvesson as new CEO

* the Board has appointed the company's current CSO Helén Tuvesson as new CEO of Active Biotech AB

Jun 19 2017

Earnings vs. Estimates